Tower Research Capital (TRC)’s ProShares Ultra Health Care RXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-11,688
Closed -$451K 6300
2022
Q3
$451K Buy
11,688
+1,738
+17% +$67.1K 0.01% 1235
2022
Q2
$434K Buy
9,950
+6,478
+187% +$283K 0.01% 1232
2022
Q1
$178K Buy
3,472
+352
+11% +$18K ﹤0.01% 1818
2021
Q4
$175K Sell
3,120
-2,590
-45% -$145K ﹤0.01% 1870
2021
Q3
$271K Buy
5,710
+1,484
+35% +$70.4K 0.01% 1518
2021
Q2
$197K Sell
4,226
-3,152
-43% -$147K 0.01% 1940
2021
Q1
$294K Sell
7,378
-6,666
-47% -$266K ﹤0.01% 1679
2020
Q4
$531K Sell
14,044
-3,528
-20% -$133K 0.02% 948
2020
Q3
$574K Sell
17,572
-1,500
-8% -$49K 0.01% 1534
2020
Q2
$560K Sell
19,072
-17,368
-48% -$510K 0.02% 919
2020
Q1
$826K Buy
36,440
+26,528
+268% +$601K 0.05% 281
2019
Q4
$315K Sell
9,912
-5,148
-34% -$164K 0.03% 429
2019
Q3
$370K Sell
15,060
-31,384
-68% -$771K 0.03% 701
2019
Q2
$1.22M Sell
46,444
-1,440
-3% -$37.9K 0.08% 213
2019
Q1
$1.25M Buy
47,884
+8,108
+20% +$212K 0.08% 210
2018
Q4
$904K Buy
39,776
+33,780
+563% +$768K 0.07% 291
2018
Q3
$174K Buy
+5,996
New +$174K 0.01% 1046
2017
Q2
Sell
-2,616
Closed -$46K 3426
2017
Q1
$46K Buy
+2,616
New +$46K ﹤0.01% 778
2016
Q2
Sell
-536
Closed -$8K 4898
2016
Q1
$8K Sell
536
-34,204
-98% -$511K ﹤0.01% 2233
2015
Q4
$573K Buy
34,740
+20,284
+140% +$335K 0.09% 109
2015
Q3
$206K Buy
14,456
+13,956
+2,791% +$199K 0.02% 282
2015
Q2
$9K Buy
500
+220
+79% +$3.96K ﹤0.01% 2818
2015
Q1
$5K Sell
280
-2,120
-88% -$37.9K ﹤0.01% 3267
2014
Q4
$37K Buy
+2,400
New +$37K ﹤0.01% 1211
2014
Q2
Sell
-4,000
Closed -$45K 4591
2014
Q1
$45K Buy
+4,000
New +$45K 0.01% 1172